TY - JOUR
T1 - Supportive care during treatment for breast cancer
T2 - Resource allocations in low- and middle-income countries: A Breast Health Global Initiative 2013 consensus statement
AU - Cardoso, Fatima
AU - Bese, Nuran
AU - Distelhorst, Sandra R.
AU - Bevilacqua, Jose Luiz B.
AU - Ginsburg, Ophira
AU - Grunberg, Steven M.
AU - Gralla, Richard J.
AU - Steyn, Ann
AU - Pagani, Olivia
AU - Partridge, Ann H.
AU - Knaul, Felicia Marie
AU - Aapro, Matti S.
AU - Andersen, Barbara L.
AU - Thompson, Beti
AU - Gralow, Julie R.
AU - Anderson, Benjamin O.
N1 - Funding Information:
BHGI 2012 Global Summit received grants and contributions from Fred Hutchinson Cancer Research Center , Susan G Komen for the Cure ® (Contract ID: INT-3063.0/Tracking No: 221664), International Atomic Energy Agency Programme of Action for Cancer Therapy , National Cancer Institute , The Lancet Oncology , Elsevier , American Society of Clinical Oncology , Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer , Pan American Health Organization , European Society of Medical Oncology , European School of Oncology , Open Society Foundations , LIVESTRONG , and an unrestricted educational grant from Sanofi .
Funding Information:
BOA received consulting compensation from GE Healthcare and Navidea Biopharmaceuticals. NB received consulting/speaking/teaching compensation from Roche. RC received grant/research support from AstraZeneca , Roche , and Genentech . RG received consulting compensation from Merck, Eisai, and Helsinn, and was on an advisory committee for AP Pharm and Sancuso. JRG received grant/research support from Amgen , Genentech, Novartis , and Roche. SG consulted for Helsinn, Merck, and Tesaro, and was on advisory committees for AP Pharma and Archimedes Pharma. FMK received grant/research support from Avon Mexico , NADRO , Chinoin Pharmaceutical , and GlaxcoSmithKline , and provided consulting for the Mexican Health Foundation, NCD Working Group, and Johns Hopkins, and received royalties/intellectual property rights from Santillama Editores. LS received grant/research support from Avon Foundation . All other authors and panel members reported no conflict of interest.
PY - 2013/10
Y1 - 2013/10
N2 - Breast cancer patients may have unmet supportive care needs during treatment, including symptom management of treatment-related toxicities, and educational, psychosocial, and spiritual needs. Delivery of supportive care is often a low priority in low- and middle-income settings, and is also dependent on resources available. This consensus statement describes twelve key recommendations for supportive care during treatment in low- and middle-income countries, identified by an expert international panel as part of the 5th Breast Health Global Initiative (BHGI) Global Summit for Supportive Care, which was held in October 2012, in Vienna, Austria. Panel recommendations are presented in a 4-tier resource-stratified table to illustrate how health systems can provide supportive care services during treatment to breast cancer patients, starting at a basic level of resource allocation and incrementally adding program resources as they become available. These recommendations include: health professional and patient and family education; management of treatment related toxicities, management of treatment-related symptoms of fatigue, insomnia and non-specific pain, and management of psychosocial and spiritual issues related to breast cancer treatment. Establishing supportive care during breast cancer treatment will help ensure that breast cancer patients receive comprehensive care that can help 1) improve adherence to treatment recommendations, 2) manage treatment-related toxicities and other treatment related symptoms, and 3) address the psychosocial and spiritual aspects of breast cancer and breast cancer treatments.
AB - Breast cancer patients may have unmet supportive care needs during treatment, including symptom management of treatment-related toxicities, and educational, psychosocial, and spiritual needs. Delivery of supportive care is often a low priority in low- and middle-income settings, and is also dependent on resources available. This consensus statement describes twelve key recommendations for supportive care during treatment in low- and middle-income countries, identified by an expert international panel as part of the 5th Breast Health Global Initiative (BHGI) Global Summit for Supportive Care, which was held in October 2012, in Vienna, Austria. Panel recommendations are presented in a 4-tier resource-stratified table to illustrate how health systems can provide supportive care services during treatment to breast cancer patients, starting at a basic level of resource allocation and incrementally adding program resources as they become available. These recommendations include: health professional and patient and family education; management of treatment related toxicities, management of treatment-related symptoms of fatigue, insomnia and non-specific pain, and management of psychosocial and spiritual issues related to breast cancer treatment. Establishing supportive care during breast cancer treatment will help ensure that breast cancer patients receive comprehensive care that can help 1) improve adherence to treatment recommendations, 2) manage treatment-related toxicities and other treatment related symptoms, and 3) address the psychosocial and spiritual aspects of breast cancer and breast cancer treatments.
KW - Breast cancer
KW - Low- and middle-income countries
KW - Resource allocations
KW - Supportive care
KW - Treatment toxicities
UR - http://www.scopus.com/inward/record.url?scp=84884149244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884149244&partnerID=8YFLogxK
U2 - 10.1016/j.breast.2013.07.050
DO - 10.1016/j.breast.2013.07.050
M3 - Review article
C2 - 24001709
AN - SCOPUS:84884149244
SN - 0960-9776
VL - 22
SP - 593
EP - 605
JO - Breast
JF - Breast
IS - 5
ER -